This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment.
Serious. These medicines may interact and cause very harmful effects. Contact your healthcare professional (e.g. doctor or pharmacist) for more information.
How the interaction occurs:
Sulfinpyrazone may slow down how quickly your body processes acenocoumarol or warfarin.
What might happen:
You may experience an increased chance for bleeding including bleeding from your gums, nosebleeds, unusual bruising, or black stools.
What you should do about this interaction:
Contact your healthcare professionals (e.g. doctor or pharmacist) as soon as possible about taking these two medicines together. Your bleeding tests may need to be checked more often until they are stabile on this combination. It may be necessary to adjust your dose of acenocoumarin or warfarin.If you have any signs of bleeding, such as bleeding from your gums, nosebleeds, unusual bruising, or dark/black/tarry stools, contact your doctor right away.Your healthcare professional may already be aware of this interaction and may be monitoring you for it. Do not start, stop, or change the dosage of any medicine before checking with them first.
1.Davis JW, Johns LE Jr. Possible interaction of sulfinpyrazone with coumarins. N Engl J Med 1978 Oct 26;299(17):955.
2.Girolami A, Fabris F, Casonato A, Randi ML. Potentiation of anticoagulant response to warfarin by sulphinpyrazone: a double-blind study in patients with prosthetic heart valves. Clin Lab Haematol 1982;4(1):23-6.
3.Johnson JA, Gong L, Whirl-Carrillo M, Gage BF, Scott SA, Stein CM, Anderson JL, Kimmel SE, Lee MT, Pirmohamed M, Wadelius M, Klein TE, Altman RB. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing. Clin Pharmacol Ther 2011 Oct;90(4):625-9.
4.O'Reilly RA. Stereoselective interaction of sulfinpyrazone with racemic warfarin and its separated enantiomorphs in man. Circulation 1982 Jan; 65(1):202-7.
5.This information is based on or an extract from the UW Metabolism and Transport Drug Interaction Database (DIDB) Platform, Copyright University of Washington 1999-2014..